Efficacy of alprostadil in preventing contrast ‐induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial

ConclusionProphylactic administration of alprostadil may prevent against CIN in coronary heart disease patients undergoing elective PCI, particularly in high‐risk patients with diabetes mellitus.

Source: Catheterization and Cardiovascular Interventions - October 10, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Min Liang, Shicheng Yang, Naikuan Fu, Chengzhi Lu, Fengshi Tian, Xiaochun Xing, Wenhua Lin, Jingjing Liu Tags: PERIPHERAL VASCULAR DISEASE Source Type: research